Age-dependent HLA Genetic Heterogeneity of Type 1 Insulin-dependent Diabetes Mellitus

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1992 Dec 1

PMID 1469084

Citations 61

Authors

S Caillat-Zucman

H J Garchon

J Timsit

R Assan

C Boitard

P Bougneres

J F Bach

Affiliations

Soon will be listed here.

Abstract

The association of insulin-dependent diabetes mellitus (IDDM) with certain HLA alleles is well documented in pediatric patients. Whether a similar association is found in adult-on-set IDDM is not clear, although the disease occurs after the age of 20 in 50% of cases. HLA class II DRB1, DQA1, and DQB1 alleles were studied in 402 type I diabetics and 405 healthy controls (all Caucasian) using oligonucleotide typing after gene amplification. Alleles DRB1*03, DRB1*04, DQB1*0201, DQB1*0302, DQA1*0301, and DQA1*0501 were indeed enriched in diabetics and the highest relative risk was observed in patients carrying both the DRB1*03-DQB1*0201 and the DRB1*0402 or DRB1*0405-DQB1*0302 haplotypes. However none of these alleles, or specific residues, could alone account for the susceptibility to IDDM. Furthermore, there were major differences in HLA class II gene profiles according to the age of onset. Patients with onset after 15 yr (n = 290) showed a significantly higher percentage of non-DR3/non-DR4 genotypes than those with childhood onset (n = 112) and a lower percentage of DR3/4 genotypes. These non-DR3/non-DR4 patients, although presenting clinically as IDDM type 1 patients, showed a lower frequency of islet cell antibodies at diagnosis and a significantly milder initial insulin deficiency. These subjects probably represent a particular subset of IDDM patients in whom frequency increases with age. The data confirm the genetic heterogeneity of IDDM and call for caution in extrapolating to adult patients the genetic concepts derived from childhood IDDM.

Citing Articles

Genomic variants associated with age at diagnosis of childhood-onset type 1 diabetes.

Bougneres P, Le Fur S, Kamatani Y, Mai T, Belot M, Perge K J Hum Genet. 2024; 69(11):585-590.

PMID: 38982180 DOI: 10.1038/s10038-024-01272-3.

Reversal of diabetes by an oral Salmonella-based vaccine in acute and progressive diabetes in NOD mice.

Cobb J, Rawson J, Gonzalez N, Orr C, Kandeel F, Husseiny M PLoS One. 2024; 19(5):e0303863.

PMID: 38781241 PMC: 11115281. DOI: 10.1371/journal.pone.0303863.

The rare DRB1*04:08-DQ8 haplotype is the main HLA class II genetic driver and discriminative factor of Early-onset Type 1 diabetes in the Portuguese population.

Caramalho I, Matoso P, Ligeiro D, Paixao T, Sobral D, Fitas A Front Immunol. 2024; 14:1299609.

PMID: 38318503 PMC: 10839680. DOI: 10.3389/fimmu.2023.1299609.

Unveiling the Link: A Comprehensive Narrative Review of the Relationship Between Type 1 Diabetes Mellitus and Celiac Disease.

Arora S, Tayade A, Bhardwaj T, Pathak S Cureus. 2023; 15(10):e47726.

PMID: 38022113 PMC: 10676227. DOI: 10.7759/cureus.47726.

DR15-DQ6 remains dominantly protective against type 1 diabetes throughout the first five decades of life.

Thomas N, Dennis J, Sharp S, Kaur A, Misra S, Walkey H Diabetologia. 2021; 64(10):2258-2265.

PMID: 34272580 PMC: 8423681. DOI: 10.1007/s00125-021-05513-4.

References

Horn G, Bugawan T, Long C, Erlich H . Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility. Proc Natl Acad Sci U S A. 1988; 85(16):6012-6. PMC: 281895. DOI: 10.1073/pnas.85.16.6012. View

Grimberg J, Nawoschik S, Belluscio L, McKee R, Turck A, Eisenberg A . A simple and efficient non-organic procedure for the isolation of genomic DNA from blood. Nucleic Acids Res. 1989; 17(20):8390. PMC: 334995. DOI: 10.1093/nar/17.20.8390. View

Assan R, Feutren G, DEBRAY-SACHS M, Laborie C, Thomas G, Chatenoud L . Metabolic and immunological effects of cyclosporin in recently diagnosed type 1 diabetes mellitus. Lancet. 1985; 1(8420):67-71. DOI: 10.1016/s0140-6736(85)91964-6. View

Michelsen B, Lernmark A . Molecular cloning of a polymorphic DNA endonuclease fragment associates insulin-dependent diabetes mellitus with HLA-DQ. J Clin Invest. 1987; 79(4):1144-52. PMC: 424296. DOI: 10.1172/JCI112931. View

Sterkers G, Zeliszewski D, Chaussee A, DESCHAMPS I, Font M, FREIDEL C . HLA-DQ rather than HLA-DR region might be involved in dominant nonsusceptibility to diabetes. Proc Natl Acad Sci U S A. 1988; 85(17):6473-7. PMC: 281995. DOI: 10.1073/pnas.85.17.6473. View

Aparicio J, Wakisaka A, Takada A, Matsuura N, Aizawa M . HLA-DQ system and insulin-dependent diabetes mellitus in Japanese: does it contribute to the development of IDDM as it does in Caucasians?. Immunogenetics. 1988; 28(4):240-6. DOI: 10.1007/BF00345500. View

Cohen-Haguenauer O, Robbins E, Massart C, Busson M, DESCHAMPS I, Hors J . A systematic study of HLA class II-beta DNA restriction fragments in insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A. 1985; 82(10):3335-9. PMC: 397770. DOI: 10.1073/pnas.82.10.3335. View

Arnheim N, Strange C, Erlich H . Use of pooled DNA samples to detect linkage disequilibrium of polymorphic restriction fragments and human disease: studies of the HLA class II loci. Proc Natl Acad Sci U S A. 1985; 82(20):6970-4. PMC: 391291. DOI: 10.1073/pnas.82.20.6970. View

Saiki R, Scharf S, Faloona F, Mullis K, Horn G, Erlich H . Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 1985; 230(4732):1350-4. DOI: 10.1126/science.2999980. View

10.

Angelini G, de Preval C, Gorski J, MACH B . High-resolution analysis of the human HLA-DR polymorphism by hybridization with sequence-specific oligonucleotide probes. Proc Natl Acad Sci U S A. 1986; 83(12):4489-93. PMC: 323759. DOI: 10.1073/pnas.83.12.4489. View

11.

Nepom B, Palmer J, Kim S, Hansen J, Holbeck S, Nepom G . Specific genomic markers for the HLA-DQ subregion discriminate between DR4+ insulin-dependent diabetes mellitus and DR4+ seropositive juvenile rheumatoid arthritis. J Exp Med. 1986; 164(1):345-50. PMC: 2188212. DOI: 10.1084/jem.164.1.345. View

12.

Segall M, Noreen H, Schluender L, Swenson M, Barbosa J, Bach F . DR2+ haplotypes in insulin-dependent diabetes: analysis of DNA restriction fragment length polymorphisms. Hum Immunol. 1986; 17(1):61-8. DOI: 10.1016/0198-8859(86)90075-3. View

13.

Thomson G, Robinson W, Kuhner M, JOE S, MacDonald M, Gottschall J . Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus. Am J Hum Genet. 1988; 43(6):799-816. PMC: 1715606. View

14.

Papoz L, Vauzelle F, Vexiau P, Cathelineau G . Pattern of treatment among diabetic patients in France. Diabetes Care. 1988; 11(7):586-91. DOI: 10.2337/diacare.11.7.586. View

15.

Foulis A, Francis N, Farquharson M, Boylston A . Massive synchronous B-cell necrosis causing type 1 (insulin-dependent) diabetes--a unique histopathological case report. Diabetologia. 1988; 31(1):46-50. DOI: 10.1007/BF00279132. View

16.

Morel P, Dorman J, Todd J, McDevitt H, Trucco M . Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study. Proc Natl Acad Sci U S A. 1988; 85(21):8111-5. PMC: 282365. DOI: 10.1073/pnas.85.21.8111. View

17.

Tait B, MRAZ G, Harrison L . Association of HLA-DQw3 (TA10-) with type I diabetes occurs with DR3/4 but not DR1/4 patients. Diabetes. 1988; 37(7):926-9. DOI: 10.2337/diab.37.7.926. View

18.

ROWE J, Mickelson E, Hansen J, MacDonald M, Allen C, GABBAY K . T-cell-defined DR4 subtypes as markers for type 1 diabetes. Hum Immunol. 1988; 22(1):51-60. DOI: 10.1016/0198-8859(88)90051-1. View

19.

Todd J, Bell J, McDevitt H . HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature. 1987; 329(6140):599-604. DOI: 10.1038/329599a0. View

20.

Scharf S, Friedmann A, Brautbar C, Szafer F, Steinman L, Horn G . HLA class II allelic variation and susceptibility to pemphigus vulgaris. Proc Natl Acad Sci U S A. 1988; 85(10):3504-8. PMC: 280240. DOI: 10.1073/pnas.85.10.3504. View